Mass Spectrometry Assay for Viral Vector Isomerohydrolase Potency

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for measuring isomerohydrolase activity are limited by the use of radioactive substrates, which pose safety and handling challenges, and lack precision and accuracy in quantifying isomerohydrolase activity across a broad range of multiplicity of infection (MOI) values.

Innovation Solution

A non-radioactive method using mass spectrometry to quantify the reaction product of isomerohydrolase activity, specifically involving the use of a viral vector encoding an isomerohydrolase protein, such as RPE65, with a non-radioactive substrate, and chromatography to purify and analyze the reaction product.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If radioactive substrates are used to measure isomerohydrolase activity, then detection sensitivity is improved, but safety risks and handling complexity increase

Engineering Contradiction:
Improvedetection sensitivityVSAvoidsafety risks
Core Design Contradiction:
Measurement precisionVSObject-affected harmful factors

Solution Approach 1:

The patent replaces the radioactive detection system with a mass spectrometry-based detection system. Instead of using radioactive substrates that require special safety handling, the invention uses non-radioactive substrates with mass spectral tags that can be detected and quantified by mass spectrometry, achieving comparable or superior detection sensitivity without the harmful radiation effects

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent introduces an intermediary detection mechanism - mass spectrometry - that mediates between the enzymatic reaction and the final measurement. Rather than directly detecting radioactive decay, the system uses mass spectrometry to detect and quantify the reaction products, providing an indirect but safer measurement pathway that eliminates radiation exposure while maintaining measurement capability

Inventive Principle:
Principle #24Intermediary (Mediator)

2Measurement precision

If radioactive substrates are used to measure isomerohydrolase activity, then detection capability is maintained, but device complexity and operational difficulty increase

Engineering Contradiction:
Improvedetection capabilityVSAvoidhandling complexity
Core Design Contradiction:
Measurement precisionVSEase of operation

Solution Approach 1:

The patent substitutes the complex radioactive material handling system with a simpler mass spectrometry-based system. The non-radioactive substrates eliminate the need for specialized containment, storage, and disposal procedures, making the assay easier to perform while maintaining detection capability through the sensitive mass spectrometric detection of reaction products

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

Solution Approach 2:

The patent employs disposable, non-radioactive substrates that can be readily prepared and discarded without special waste handling procedures. These substrates with mass spectral tags are designed for single-use in the assay, eliminating the long-term storage and regulatory compliance requirements associated with radioactive materials while maintaining detection sensitivity

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

3Measurement precision

If conventional methods are used to quantify isomerohydrolase activity, then measurement is possible, but precision and accuracy across broad MOI ranges are insufficient

Engineering Contradiction:
Improvequantification accuracyVSAvoidrange of MOI values
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent employs a dynamic detection approach using mass spectrometry that can adapt to varying substrate concentrations and reaction rates across different MOI values. The system dynamically adjusts detection parameters and uses internal standards to maintain quantification accuracy across a broad range of enzymatic activities, from low to high MOI conditions

Inventive Principle:
Principle #15Dynamics

Solution Approach 2:

The patent utilizes parameter changes in the mass spectrometry detection system to optimize measurement across different MOI ranges. By adjusting mass spectral acquisition parameters, collision energies, and quantification algorithms, the system maintains high precision and accuracy whether measuring low-level or high-level isomerohydrolase activity, extending the usable MOI range

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The method provides accurate and precise measurement of isomerohydrolase activity over a broad range of MOI values, ensuring high precision and safety by eliminating radioactive materials.

Implementation Method 1

The invention provides methods for measuring and/or detecting isomerohydrolase activity. In certain embodiments, methods include the use of mass spectrometry to quantify the reaction product thereby measuring and/or detecting isomerohydrolase activity.

Methodology Applied
Scientific EffectMass spectrometry:

Implementation Method 2

subjecting the reaction product to column (liquid) chromatography thereby producing a column (liquid) chromatography purified reaction product

Methodology Applied
Scientific EffectColumn chromatography: Chromatography

Implementation Method 3

incubating the extract (e.g., cell extract) with a substrate for a period of time and under conditions allowing conversion of the substrate by the isomerohydrolase protein to a reaction product

Methodology Applied
Scientific EffectEnzymatic isomerohydrolase activity: Enzyme

Data Source

PatentUS20250305024A1Relative potency assay for viral vector encoding isomerohydrolases
Publication Date: 2025.10.02 SPARK THERAPEUTICS INC
  • US20250305024A1 patent drawing
  • US20250305024A1 patent drawing
  • US20250305024A1 patent drawing

AI summary

Methods for assaying function and/or activity and/or potency of isomerohydrolase proteins are provided.